Computational Drug Repurposing Algorithm Targeting TRPA1 Calcium Channel as a Potential Therapeutic Solution for Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (CNS) through neurodegeneration and demyelination, leading to physical/cognitive disability and neurological defects. A viable target for treating MS appears to be the Transient Receptor Potential Ankyrin 1...
Main Authors: | Dragos Paul Mihai, George Mihai Nitulescu, George Nicolae Daniel Ion, Cosmin Ionut Ciotu, Cornel Chirita, Simona Negres |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/9/446 |
Similar Items
-
Effects of Venlafaxine, Risperidone and Febuxostat on Cuprizone-Induced Demyelination, Behavioral Deficits and Oxidative Stress
by: Dragos Paul Mihai, et al.
Published: (2021-07-01) -
In silico drug repurposing: An antifungal drug, itraconazole, repurposed as an anticancer agent using molecular docking
by: Sanika Dhorje, et al.
Published: (2020-01-01) -
Computational Drug Repurposing for Antituberculosis Therapy: Discovery of Multi-Strain Inhibitors
by: Valeria V. Kleandrova, et al.
Published: (2021-08-01) -
Tree-Based QSAR Model for Drug Repurposing in the Discovery of New Antibacterial Compounds Against <i>Escherichia coli</i>.
by: Beatriz Suay-Garcia, et al.
Published: (2020-11-01) -
Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
by: Simon R. W. Stott, et al.
Published: (2021-03-01)